Jiménez-Yuste V - Search Results

1

Practical aspects of extended half-life products for the treatment of haemophilia.

Lambert T, Benson G, Dolan G, Hermans C, Jiménez-Yuste V, Ljung R, Morfini M, Zupančić-Šalek S, Santagostino E. Lambert T, et al. Ther Adv Hematol. 2018 Sep 6;9(9):295-308. doi: 10.1177/2040620718796429. eCollection 2018 Sep. Ther Adv Hematol. 2018. PMID: 30210757 Free PMC article. Review.

2

Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?

Rodriguez-Merchan EC, Hedner U, Heijnen L, Jimenez-Yuste V, Lee CA, Morfini M, Querol F, Roosendaal G, Santagostino E, Solimeno LP. Rodriguez-Merchan EC, et al. Haemophilia. 2008 Nov;14 Suppl 6:68-81. doi: 10.1111/j.1365-2516.2008.01892.x. Haemophilia. 2008. PMID: 19134036

3

Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs.

Santagostino E, Morfini M, Auerswald GK, Benson GM, Salek SZ, Lambert T, Salaj P, Jimenez-Yuste V, Ljung RC. Santagostino E, et al. Haemophilia. 2009 Sep;15(5):983-9. doi: 10.1111/j.1365-2516.2009.01999.x. Haemophilia. 2009. PMID: 19712172 Review.

4

When should prophylaxis therapy in inhibitor patients be considered?

Young G, Auerswald G, Jimenez-Yuste V, Konkle BA, Lambert T, Morfini M, Santagostino E, Blanchette V. Young G, et al. Haemophilia. 2011 Sep;17(5):e849-57. doi: 10.1111/j.1365-2516.2011.02494.x. Epub 2011 Mar 21. Haemophilia. 2011. PMID: 21418444 Review.

5

Joint protection in haemophilia.

Rodriguez-Merchan EC, Jimenez-Yuste V, Aznar JA, Hedner U, Knobe K, Lee CA, Ljung R, Querol F, Santagostino E, Valentino LA, Caffarini A. Rodriguez-Merchan EC, et al. Haemophilia. 2011 Sep;17 Suppl 2:1-23. doi: 10.1111/j.1365-2516.2011.02615.x. Haemophilia. 2011. PMID: 21819491 Review.

6

Pharmacokinetic properties of two different recombinant activated factor VII formulations.

Morfini M, Jiménez-Yuste V, Eichler H, Fischer R, Kirchmaier CM, Scharling B, Bjerre J. Morfini M, et al. Haemophilia. 2012 May;18(3):431-6. doi: 10.1111/j.1365-2516.2011.02674.x. Epub 2011 Oct 17. Haemophilia. 2012. PMID: 21999231 Clinical Trial.

7

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Collins P, Baudo F, Knoebl P, Lévesque H, Nemes L, Pellegrini F, Marco P, Tengborn L, Huth-Kühne A; EACH2 registry collaborators. Collins P, et al. Blood. 2012 Jul 5;120(1):47-55. doi: 10.1182/blood-2012-02-409185. Epub 2012 Apr 18. Blood. 2012. PMID: 22517903 Free PMC article.

8

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.

Baudo F, Collins P, Huth-Kühne A, Lévesque H, Marco P, Nemes L, Pellegrini F, Tengborn L, Knoebl P; EACH2 registry contributors. Baudo F, et al. Blood. 2012 Jul 5;120(1):39-46. doi: 10.1182/blood-2012-02-408930. Epub 2012 May 22. Blood. 2012. PMID: 22618709 Free article.

9

Optimizing joint function: new knowledge and novel tools and treatments.

Monahan PE, Doria AS, Ljung R, Jiménez-Yuste V. Monahan PE, et al. Haemophilia. 2012 Jul;18 Suppl 5:17-26. doi: 10.1111/j.1365-2516.2012.02888.x. Haemophilia. 2012. PMID: 22757680

10

PRO-PACT: retrospective observational study on the prophylactic use of recombinant factor VIIa in hemophilia patients with inhibitors.

Young G, Auerswald G, Jimenez-Yuste V, Lambert T, Morfini M, Santagostino E, Blanchette V. Young G, et al. Thromb Res. 2012 Dec;130(6):864-70. doi: 10.1016/j.thromres.2012.08.305. Epub 2012 Sep 8. Thromb Res. 2012. PMID: 22964026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters